Table 4.
Prognostic analysis in different population.
| Site of Metastasis | OS | CSS | |
|---|---|---|---|
| Bone | MST (month) | 3 | 4 |
| 6-month SR (%) | 35.6 | 38.2 | |
| 1-year SR (%) | 20.0 | 21.5 | |
| 3-year SR (%) | 1.9 | 2.7 | |
| Brain | MST (month) | 5 | 6 |
| 6-month SR (%) | 36.4 | 40.6 | |
| 1-year SR (%) | 27.3 | 30.4 | |
| 3-year SR (%) | 0 | 0 | |
| Liver | MST (month) | 4 | 4 |
| 6-month SR (%) | 36.5 | 38.6 | |
| 1-year SR (%) | 21.1 | 23.6 | |
| 3-year SR (%) | 2.1 | 2.5 | |
| Lung | MST (month) | 3 | 4 |
| 6-month SR (%) | 43.5 | 45.6 | |
| 1-year SR (%) | 23.9 | 28.2 | |
| 3-year SR (%) | 4.9 | 8.4 | |
| Multiple | MST (month) | 2 | 3 |
| 6-month SR (%) | 27.1 | 29.9 | |
| 1-year SR (%) | 10.7 | 12.0 | |
| 3-year SR (%) | 2.5 | 2.8 | |
| Total | MST (month) | 3 | 4 |
| 6-month SR (%) | 34.3 | 36.8 | |
| 1-year SR (%) | 18.1 | 20.5 | |
| 3-year SR (%) | 2.4 | 3.2 |
OS, overall survival; CSS, cancer-specific survival; MST, median survival time; yrs, years; SR, survival rate.